Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Henry Schein Animal Health to merge with Vets First Choice
Henry Schein and Vets First Choice expect the new business to grow such that in year three, operating income synergies will be in excess of $100 million.
Spin off to bring new global animal health company 

Henry Schein is set to spin off its animal health business and merge with Vets First Choice, launching a new public company.

The new company, called Vets First Corp., will be headquartered in Portland, Maine. It is promising to ‘provide veterinarians with a powerful new platform to grow their practices, improve client engagement, and drive better health outcomes for pets’.

Upon completion of the transaction, Henry Schein shareholders will own approximately 63 per cent of the new company, while Vets First Choice shareholders will own 37 per cent. Henry Schein is expected to receive $1-1.25 billion in cash on a tax-free basis.

Ben Shaw, founder and CEO of Vets First Choice, who will become CEO of the new company, said: "This merger creates an enhanced value chain that connects the veterinarian, the manufacturer, and the pet owner through insights and analytics that will support better clinical and financial outcomes.

“This new global animal health care company is focused on improving clinical compliance by facilitating the delivery of care how, when, and where the pet owner wants it."

Henry Schein and Vets First Choice expect the new business to grow such that in year three, operating income synergies will be in excess of $100 million.

The transaction is expected to close by the end of 2018. 

Become a member or log in to add this story to your CPD history

Submissions open for BSAVA Clinical Research Abstracts 2026

News Story 1
 The BSAVA has opened submissions for the BSAVA Clinical Research Abstracts 2026.

It is an opportunity for applicants to present new research on any veterinary subject, such as the preliminary results of a study, discussion of a new technique or a description of an interesting case.

They must be based on high-quality clinical research conducted in industry, practice or academia, and summarised in 250 words.

Applications are welcome from vets, vet nurses, practice managers, and students.

Submissions are open until 6 March 2026. 

Click here for more...
News Shorts
Survey seeks ruminant sector views on antimicrobial stewardship

A new survey is seeking views of people working in the UK ruminant sector on how to tackle the challenge of demonstrating responsible antibiotic stewardship.

Forming part of a wider, collaborative initiative, the results will help identify the types of data available so that challenges with data collection can be better understood and addressed.

Anyone working in the UK farming sector, including vets and farmers,is encouraged to complete the survey, which is available at app.onlinesurveys.jisc.ac.uk